Qube Research & Technologies LTD Spring Works Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 195,396 shares of SWTX stock, worth $6.91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
195,396
Previous 24,194
707.62%
Holding current value
$6.91 Million
Previous $1.19 Million
518.49%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$231 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$199 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$131 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$127 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$121 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.21B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...